Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G Davey

Showing results (21-30 of 106) with videos related to

Pageof 11
Sort By:
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1980
The compromised host and antibacterial treatmentA M Geddes, P G Davey
Pharmacoeconomics|January 9, 1992
Pharmacoeconomics of intravenous drug administrationS E Parker, P G Davey
Lancet (London, England)|February 6, 1993
Once-daily aminoglycoside dosingS E Parker, P G Davey
Lancet (London, England)|October 15, 1988
Ciprofloxacin and tenosynovitisS R McEwan, P G Davey
The Journal of Antimicrobial Chemotherapy|April 1, 1991
Teicoplanin monotherapy of serious infections caused by gram-positive bacteria: a re-evaluation of patients with endocarditis or Staphylococcus aureus bacteraemia from a European open trialP G Davey, A H Williams
The Journal of Antimicrobial Chemotherapy|April 1, 1991
A review of the safety profile of teicoplaninP G Davey, A H Williams
The New England Journal of Medicine|December 27, 1979
Secondary spread of H. influenzaeP G Davey, J K Cruckshank
Pharmacoeconomics|April 8, 1993
The reliability of cost-utility estimates in cost-per-QALY league tables S Petrou, M Malek, P G Davey
The Journal of Antimicrobial Chemotherapy|March 1, 1991
Bronchial penetration of ofloxacin after single and multiple oral dosageP G Davey, E Precious, J Winter
The Journal of Infectious Diseases|March 1, 1987
Dose response of experimental Pseudomonas endophthalmitis to ciprofloxacin, gentamicin, and imipenem: evidence for resistance to "late" treatment of infectionsP G Davey, M Barza, M Stuart
Pageof 11

Showing results (21-30 of 106) with videos related to

Sort By:
Pageof 11
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1980
The compromised host and antibacterial treatmentA M Geddes, P G Davey
Pharmacoeconomics|January 9, 1992
Pharmacoeconomics of intravenous drug administrationS E Parker, P G Davey
Lancet (London, England)|February 6, 1993
Once-daily aminoglycoside dosingS E Parker, P G Davey
Lancet (London, England)|October 15, 1988
Ciprofloxacin and tenosynovitisS R McEwan, P G Davey
The Journal of Antimicrobial Chemotherapy|April 1, 1991
Teicoplanin monotherapy of serious infections caused by gram-positive bacteria: a re-evaluation of patients with endocarditis or Staphylococcus aureus bacteraemia from a European open trialP G Davey, A H Williams
The Journal of Antimicrobial Chemotherapy|April 1, 1991
A review of the safety profile of teicoplaninP G Davey, A H Williams
The New England Journal of Medicine|December 27, 1979
Secondary spread of H. influenzaeP G Davey, J K Cruckshank
Pharmacoeconomics|April 8, 1993
The reliability of cost-utility estimates in cost-per-QALY league tables S Petrou, M Malek, P G Davey
The Journal of Antimicrobial Chemotherapy|March 1, 1991
Bronchial penetration of ofloxacin after single and multiple oral dosageP G Davey, E Precious, J Winter
The Journal of Infectious Diseases|March 1, 1987
Dose response of experimental Pseudomonas endophthalmitis to ciprofloxacin, gentamicin, and imipenem: evidence for resistance to "late" treatment of infectionsP G Davey, M Barza, M Stuart
Pageof 11